Financials
Value Q3, 25Q4, 25 TTM Selling/general/admin expenses 85.89 M114.81 M — Research & development —— — Operating income 37.2 M-23.5 M — Non-Operating Income, Total -32.74 M-22.68 M — Interest expense, net of interest capitalized 28.18 M13.55 M — Non-Operating Income, excl. Interest Expenses -61.05 M-29.48 M — Unusual income/expense 123 K-6.75 M — Pretax income 4.46 M-46.17 M — Equity in earnings 24 K595 K — Taxes 4.08 M8.5 M — Non-controlling/minority interest 955 K-21.95 M — After tax other income/expense —— — Net income before discontinued operations -576 K-32.72 M — Discontinued operations —— — Net income -576 K-32.72 M — Dilution adjustment —— — Preferred dividends —— — Diluted net income available to common stockholders -576 K33.8 M — Basic earnings per share (Basic EPS) —-0.57 — Diluted earnings per share (Diluted EPS) -0.01-0.57 — Average basic shares outstanding 58.51 M59.38 M — Diluted shares outstanding 58.51 M59.38 M — EBITDA 179.26 M174.51 M — EBIT 117.38 M92.17 M — Cost of revenue 559.95 M590.15 M — Other cost of goods sold —— — Depreciation & amortization (cash flow) 61.89 M82.34 M —